During the past decade, Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 19 clinical trials were completed, i.e. on average, 126.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj" #1 sponsor was "Pfizer" with 13 trials, followed by "Amgen" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Actelion" with 1 trials sponsored and "Boston Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj" are "Rheumatoid Arthritis" (6 trials), "Psoriatic Arthritis" (4 trials), "Arthritis, Rheumatoid" (3 trials), "Arthritis, Psoriatic" (2 trials) and "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj" in a lesser frequency.

Most popular intervention types in "Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj" are "Drug" (20 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Tofacitinib" (4 trials), "Adalimumab" (2 trials), "Nipocalimab" (2 trials) and "PF-06410293" (2 trials). Other intervention names were less common.

The vast majority of trials in "Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Prywatna Praktyka Lekarska Prof. UM Dr Hab. Med. Pawel Hrycaj, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".